Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding

BACKGROUND: Patients with liver disease have complex haemostasis and due to such contraindications, landmark randomised controlled trials investigating antithrombotic medicines have often excluded these patients. As a result, there has been limited consensus on the safety, efficacy and monitoring pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wai Hoong, Mueller, Stefanie H., Tan, Yen Yi, Lai, Alvina G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589727/
https://www.ncbi.nlm.nih.gov/pubmed/34806071
http://dx.doi.org/10.1016/j.lanepe.2021.100222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589727/
https://www.ncbi.nlm.nih.gov/pubmed/34806071
http://dx.doi.org/10.1016/j.lanepe.2021.100222

Ejemplares similares